| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 02/18/2014 | US8652523 Oral pharmaceutical formulation in the form of a plurality of microcapsules for prolonged release of active principle(s) with slow solubility |
| 02/18/2014 | US8652522 Pharmaceutical composition of an iontophoresis |
| 02/18/2014 | US8652521 Coated solid preparation |
| 02/18/2014 | US8652520 Combination tablet with chewable outer layer |
| 02/18/2014 | US8652519 Dissolution properties of drug products containing olmesartan medoxomil |
| 02/18/2014 | US8652518 Compositions and methods for the prevention and treatment of diseases or conditions associated with oxidative stress, inflammation, and metabolic dysregulation |
| 02/18/2014 | US8652517 Coating of tablet cores |
| 02/18/2014 | US8652516 Doxycycline formulations, and methods of treating rosacea |
| 02/18/2014 | US8652515 Pharmaceutical formulation containing an opioid agonist, opioid antagonist and irritant agent |
| 02/18/2014 | US8652514 Antimicrobial peptides |
| 02/18/2014 | US8652513 Film-forming starchy composition |
| 02/18/2014 | US8652512 Nebulized liposomes for the pulmonary application of drug compounds |
| 02/18/2014 | US8652509 Method of wound hemostasis using liquid gallium nitrate |
| 02/18/2014 | US8652497 Pharmaceutical formulation containing irritant |
| 02/18/2014 | US8652494 Composition for cosmetic, pharmaceutical or dietary applications |
| 02/18/2014 | US8652492 Wet granulation using a water sequestering agent |
| 02/18/2014 | US8652491 Transdermal compositions for anticholinergic agents |
| 02/18/2014 | US8652487 Tolerogenic synthetic nanocarriers for inducing regulatory B cells |
| 02/18/2014 | US8652464 Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer |
| 02/18/2014 | US8652443 Foamable microemulsion compositions for topical administration |
| 02/18/2014 | CA2755954C Quaternary quinuclidine derivatives and their use as muscarinic receptor antagonists |
| 02/18/2014 | CA2755809C Unit doses, aerosols, kits, and methods for treating heart conditions by pulmonary administration |
| 02/18/2014 | CA2737102C Benzimidazole anthelmintic compositions |
| 02/18/2014 | CA2736965C Extended release tablet formulation containing pramipexole or a pharmaceutically acceptable salt thereof, method for manufacturing the same and use thereof |
| 02/18/2014 | CA2667167C Hydroxypropyl methyl cellulose hard capsules and process of manufacture |
| 02/18/2014 | CA2634394C Homogeneous paste formulations |
| 02/18/2014 | CA2621079C Dried milled granulate and methods |
| 02/18/2014 | CA2611715C Methods and systems for neural maintenance and regeneration |
| 02/18/2014 | CA2607360C Solid dosage formulations of narcotic drugs having improved buccal adsorption |
| 02/18/2014 | CA2589736C Coated drug delivery formulations |
| 02/18/2014 | CA2587805C Improved vitamin d content uniformity in pharmaceutical dosage forms |
| 02/18/2014 | CA2575988C Methods for manufacturing delivery devices and devices thereof |
| 02/18/2014 | CA2575793C Natural extract containing xanthohumol, and method for the production thereof and products produced therefrom |
| 02/18/2014 | CA2500742C Compositions of fgf-18 and hyaluronic acid for stimulating cartilage production and treating osteoarthritis |
| 02/18/2014 | CA2496317C Method of producing hydroxyalkyl starch derivatives |
| 02/18/2014 | CA2454756C Methods and compounds for the targeting of protein to exosomes |
| 02/18/2014 | CA2451741C Peyers's patch and/or m-celle targeting ligands |
| 02/18/2014 | CA2429814C Rna interference mediating small rna molecules |
| 02/13/2014 | WO2014026161A1 Vitamin supplement compositions for injection |
| 02/13/2014 | WO2014026073A1 Compositions with increased stability for inhibiting transient receptor potential ion channel trpa1 |
| 02/13/2014 | WO2014025979A1 Compositions comprising spicamycin derivatives and methods of use thereof |
| 02/13/2014 | WO2014025974A1 Autologous cell-based therapy for treating obesity |
| 02/13/2014 | WO2014025890A1 Drug delivery vehicle comprising conjugates between targeting polyamino acids and fatty acids |
| 02/13/2014 | WO2014025807A1 Pharmaceutical compositions comprising l-leucovorin |
| 02/13/2014 | WO2014025672A1 Water-soluble lipophilic natural compound formulations |
| 02/13/2014 | WO2014025365A1 Eyelid treatment |
| 02/13/2014 | WO2014025290A1 External therapy remedy for patients with atopic dermatitis |
| 02/13/2014 | WO2014025206A1 Fast-dissolving oral film preparation comprising aripiprazole |
| 02/13/2014 | WO2014025042A1 Stable oxaliplatin-encapsulating liposome aqueous dispersion and method for stabilizing same |
| 02/13/2014 | WO2014024971A1 Microcapsule-manufacturing process and microcapsules |
| 02/13/2014 | WO2014024896A1 Adhesive patch agent containing agomelatine |
| 02/13/2014 | WO2014024268A1 Medicine |
| 02/13/2014 | WO2014024193A1 Compositions and methods for rapid transmucosal delivery of pharmaceutical ingredients |
| 02/13/2014 | WO2014023867A2 Empty liposomes as adjuvant for various active principles, administered independently in the conventional galenic form thereof |
| 02/13/2014 | WO2014023797A1 Intrauterine device |
| 02/13/2014 | WO2014023710A1 UNCOATED TABLET COMPRISING GRANULES INCLUDING A β-LACTAM ANTIBIOTIC AND HIGHLY DISPERSED SILICONE DIOXIDE |
| 02/13/2014 | WO2014023698A1 Eprotirome for use in the prevention and/or treatment of hair disorders and compositions thereof |
| 02/13/2014 | WO2014023652A1 Pharmaceutical formulation comprising tapentadol and cyclodextrin |
| 02/13/2014 | WO2014023421A1 Liposome composition for use in peritoneal dialysis |
| 02/13/2014 | WO2014023288A1 Method for introducing biologically active substances into the brain |
| 02/13/2014 | WO2013188273A8 Topical ophthalmological pharmaceutical composition containing axitinib |
| 02/13/2014 | WO2013188268A8 Topical ophthalmological pharmaceutical composition containing pazopanib |
| 02/13/2014 | US20140046293 Method Of Drug Delivery For PTH, PTHrP And Related Peptides |
| 02/13/2014 | US20140046292 Method Of Drug Delivery For PTH, PTHrP And Related Peptides |
| 02/13/2014 | US20140046287 Microfabricated nanopore device for sustained release of therapeutic agent |
| 02/13/2014 | US20140046279 Method for preventing the crystallisation of pharmaceuticals in a polymer film |
| 02/13/2014 | US20140046276 Wound care product |
| 02/13/2014 | US20140046275 Method for Treating Overactive Bladders and a Device for Storage and Administration of Topical Oxybutynin Compositions |
| 02/13/2014 | US20140046274 Piroxicam-containing matrix patches and methods for the topical treatment of acute and chronic pain and inflammation therewith |
| 02/13/2014 | US20140046255 Free-standing biodegradable patch |
| 02/13/2014 | US20140046242 Delivery of corticosteroids through iontophoresis |
| 02/13/2014 | US20140045951 Synthetic vitreous material |
| 02/13/2014 | US20140045948 Kit of ophthalmic composition |
| 02/13/2014 | US20140045942 Topical composition |
| 02/13/2014 | US20140045939 Ophthalmic compositions and methods for treating eyes |
| 02/13/2014 | US20140045927 Preparations of taxanes for intravenous administration and the preparation method thereof |
| 02/13/2014 | US20140045880 Pharmaceutical compositions comprising dextromethorphan and quinidine for the treatment of neurological disorders |
| 02/13/2014 | US20140045878 Matrix for sustained, invariant and independent release of active compounds |
| 02/13/2014 | US20140045877 Pharmaceutical preparation containing oxycodone and naloxone |
| 02/13/2014 | US20140045780 Compositions comprising spicamycin derivatives and methods of use thereof |
| 02/13/2014 | US20140045773 Ophthalmic compositions and methods for treating eyes |
| 02/13/2014 | US20140045772 Cyclosporin compositions |
| 02/13/2014 | US20140045745 Diketopiperazine microparticles with defined specific surface areas |
| 02/13/2014 | US20140045692 Nanocapsulation of essential oils for preventing or curing infectious diseases alone or with an antibiotic |
| 02/13/2014 | US20140044883 Paper tissue with high lotion transferability |
| 02/13/2014 | US20140044794 Drug Delivery Particle and Method for Producing the Same |
| 02/13/2014 | US20140044793 Microencapsulation process and product |
| 02/13/2014 | US20140044790 Apparatus and method for cryogranulating a pharmaceutical composition |
| 02/13/2014 | US20140044789 Melanin nanoshells for protection against radiation and electronic pulses |
| 02/13/2014 | US20140044787 Controlled release pharmaceutical compositions |
| 02/13/2014 | US20140044784 Combined formulation with improved stability |
| 02/13/2014 | US20140044783 Pharmaceutical composition comprising a thiazolidinedione |
| 02/13/2014 | US20140044782 Controlled release formulations of opioid and nonopioid analgesics |
| 02/13/2014 | US20140044781 Pharmaceutical Compositions Of Carvedilol Salts And Process For Preparation Thereof |
| 02/13/2014 | US20140044780 Extended-Release Levetiracetam and Method of Preparation |
| 02/13/2014 | US20140044778 NANOPARTICLES CONTAINING pH-RESPONSIVE PEPTIDE |
| 02/13/2014 | US20140044777 Liposome Composition |
| 02/13/2014 | US20140044776 Serpin drugs for treatment of viral infection and method of use thereof |
| 02/13/2014 | US20140044772 Liposomal apparatus and manufacturing methods |
| 02/13/2014 | US20140044761 Hybrid fragrance encapsulate formulation and method for using the same |